These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Treatment of adult acute lymphoblastic leukemia by KHALL-93--long-term outcome].
    Author: Usuki K, Adachi Y, Kazama K, Iki S, Urabe A.
    Journal: Gan To Kagaku Ryoho; 2000 Aug; 27(9):1397-402. PubMed ID: 10969595.
    Abstract:
    Twelve previously untreated adult patients with acute lymphoblastic leukemia were treated with a KHALL-93 regimen. The mean age was 46.9 years. Four patients (1/3) were over 60 years old, and 5 were Ph1 positive (42%). The complete remission rate was 100%. The 5-year survival was 50% (6/12). The 5-year event-free survival was 50% (6/12) in total, 71% (5/7) in Ph1 negative patients, and 63% (5/8) in patients younger than 60 years old. These results indicate that a KHALL-93 regimen is an effective therapy for adult acute lymphoblastic leukemia.
    [Abstract] [Full Text] [Related] [New Search]